Gestational Trophoblastic Disease: Current Evaluation and Management

Area of Science:

• Gynecology
• Reproductive Endocrinology
• Oncology

Background:

• Gestational trophoblastic disease (GTD) encompasses a spectrum of pregnancy-related trophoblastic tissue abnormalities.
• Effective management is crucial to prevent complications and malignant transformation.

Purpose of the Study:

• To review current diagnostic and management strategies for GTD.
• To emphasize the importance of prompt diagnosis and individualized treatment for GTD and gestational trophoblastic neoplasia (GTN).

Main Methods:

• Review of current literature and guidelines on GTD evaluation and management.
• Discussion of diagnostic criteria and staging for GTN.
• Outline of treatment approaches based on risk stratification.

Main Results:

• Most women with GTD can be managed successfully while preserving reproductive function.
• Proper management of molar pregnancies minimizes acute complications.
• Timely diagnosis and appropriate treatment of GTN are essential for favorable outcomes.

Conclusions:

• Individualized treatment, tailored to risk factors, is key for GTN management.
• Low-risk GTN may be treated with less toxic therapies, while high-risk GTN requires aggressive multiagent chemotherapy.
• Management of GTN should involve specialists experienced in complex, multimodality treatment.